MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.700
-0.170 (-4.39%)
Nov 4, 2024, 4:00 PM EST - Market closed
MacroGenics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for MacroGenics stock have an average target of 8.89, with a low estimate of 4.00 and a high estimate of 17. The average target predicts an increase of 140.27% from the current stock price of 3.70.
Analyst Consensus: Buy
* Price targets were last updated on Sep 18, 2024.
Analyst Ratings
The average analyst rating for MacroGenics stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 6 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +8.11% | Sep 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +8.11% | Aug 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +278.38% | Aug 15, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $8 → $5 | Hold | Maintains | $8 → $5 | +35.14% | Aug 7, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 1, 2024 |
Financial Forecast
Revenue This Year
123.46M
from 58.75M
Increased by 110.15%
Revenue Next Year
86.55M
from 123.46M
Decreased by -29.90%
EPS This Year
-2.05
from -0.15
EPS Next Year
-2.62
from -2.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 195.3M | 145.7M | 264.1M | ||
| Avg | 123.5M | 86.6M | 94.3M | ||
| Low | 43.7M | 46.4M | 21.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 232.4% | 18.0% | 205.1% | ||
| Avg | 110.1% | -29.9% | 8.9% | ||
| Low | -25.6% | -62.5% | -74.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.38 | -1.49 | -0.39 | ||
| Avg | -2.05 | -2.62 | -2.11 | ||
| Low | -3.47 | -3.97 | -4.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.